Introducing a new series on intrapartum care in the journal Best Practice and Research in Obstetrics and Gynaecology, Concept CF Executive Director A. Metin Gülmezoglu discusses the importance of respectful care and how care during childbirth needs to be...
New beginnings @ConceptFNDN When I started working on the heat stable carbetocin project in 2012 at the Special Programme of Research on Human Reproduction (HRP), a public private partnership between WHO/HRP, Ferring Pharmaceuticals and MSD for Mothers I was...
Access to quality magnesium sulfate and implementation of guidelines can help reduce maternal deaths due to preeclampsia. When a mother dies, the impact of her death reaches much further than the individual tragedy. It affects the life and health of the family,...
Appropriate Storage and Management of Oxytocin - a Key Commodity for Maternal Health
We are pleased to share the announcement of the results of the clinical trial comparing heat stable carbetocin and oxytocin in prevention of postpartum haemorrhage.
Concept Foundation has contributed to the 2018 Maternal Health Campaign. Learn more about the impact of poor quality medicines from key thought leaders.
Two publications were released recently that provide significant new evidence on uterotonics used for prevention and treatment of postpartum haemorrhage.
Concept Foundation is pleased to announce that over the coming year it will be working to address maternal health supply gaps in Ethiopia, with a new grant from the RHSC Innovation Fund.
A third mifepristone product, manufactured by Acme Formulation in India, has received a positive score for procurement by the Expert Review Panel (ERP).
Fiona Theunissen, MBA and Dr Hans Vemer, CEO of Concept Foundation and former obstetrician, discuss why quality, which is by no means a given, is such an important consideration when purchasing maternal health medicines such as uterotonics.